Physiotherapy Intervention Program for Chronic Pain Associated With Depressive Disorder
Effects of a Hybrid Physiotherapy Program Based on Pain Neuroscience Education and Therapeutic Exercise in Individuals With Chronic Persistent Pain and Depressive Disorder: A Prospective Longitudinal Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zaragoza, Spain
- Zaragoza University and San Jorge University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 45-75 years
- User of AFDA and ASAPME
- Chronic persistent pain
- Written informed consent provided
Exclusion Criteria:
- Severe psychiatric disorders (including schizophrenia)
- Neurological diseases preventing participation
- No internet access
- Mini-Mental State Examination score ≤24
- Acute musculoskeletal disorders
- Rheumatic diseases
- Severe respiratory insufficiency
- Inability to understand Spanish
- Pregnancy, immunosuppression, transplantation or active oncological condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Hybrid Physiotherapy Program
Hybrid Physiotherapy Program consisted of Pain Neuroscience Education and Therapeutic Exercise
|
Hybrid Physiotherapy Program consisted of Pain Neuroscience Education and Therapeutic Exercise: Behavioral: Pain Neuroscience Education Eight weekly face-to-face educational sessions complemented by asynchronous telematic educational videos covering pain neurophysiology, biopsychosocial approaches, neuroplasticity, motor imagery and self-management strategies. Behavioral: Therapeutic Exercise Eight weeks of supervised group exercise. Exercises include strength, aerobic, balance, flexibility, coordination and dual-task activities. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity (Numering Rating Scale)
Time Frame: Baseline and Week 8
|
It is a numerical scale ranging from 1 to 10, where 1 represents the absence of pain and 10 represents the highest intensity.
|
Baseline and Week 8
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Catastrophizing Scale
Time Frame: Baseline and Week 8
|
This scale indicates the extent to which each of the 13 thoughts described is experienced.
They are rated on a Likert scale ranging from 0 ('never') to 4 ('always').
The total score is calculated, with 52 being the maximum score.
Low scores indicate low levels of catastrophising, whilst high scores indicate high levels of catastrophising.
|
Baseline and Week 8
|
|
Chronic Pain Coping Questionnaire
Time Frame: Baseline and Week 8
|
The scale assesses the way in which patients cope with pain.
It comprises six factors to be measured: religion, catharsis, distraction, mental self-control, self-affirmation and information-seeking.
Within each factor there are between 5 and 6 items scored on a scale of 0 to 4, where 0 means 'strongly disagree' and 4 means 'strongly agree'.
Greater use of active strategies such as distraction, self-affirmation or seeking information is associated with better emotional adjustment.
Taken together, the score obtained provides an insight into how pain is coped with.
|
Baseline and Week 8
|
|
Tampa Scale for Kinesiophobia (TSK-11)
Time Frame: Baseline and Week 8
|
11-item self-report questionnaire that assesses perceptions of frailty and the tendency to avoid movement for fear of injury or increased pain.
Each item is scored on a 4-point scale (1: strongly disagree; 4: strongly agree).
A high score on the TSK-11 indicates a greater fear of movement, a greater perception of physical frailty and a more pronounced tendency to avoid activities for fear of pain or injury.
Conversely, low scores reflect lower kinesiophobia and a more confident attitude towards movement.
|
Baseline and Week 8
|
|
Chronic Pain Self-Efficacy Questionnaire
Time Frame: Baseline and Week 8
|
This questionnaire consists of 19 items designed to assess the patient's confidence in their own ability to carry out various activities and manage the consequences of persistent pain.
The scale is divided into three main domains or subscales: self-efficacy for pain control, for physical function and for symptom management.
Each item is rated on a scale ranging from 0 ('completely unable') to 10 ('completely able').
A high score on this scale indicates a greater perceived ability to manage pain, maintain activity and manage symptoms, whilst low scores reflect lower confidence, greater dependence and poorer coping.
|
Baseline and Week 8
|
|
Depression Anxiety Stress Scale (DASS-21)
Time Frame: Baseline and Week 8
|
The DASS-21 scale measures patients' emotional state and is used to assess three distinct areas: depression, anxiety and stress.
This scale consists of 21 questions divided into three groups of seven items each.
For each question, the patient must assign a score from 0 to 3, where 0 means that 'nothing has happened' and 3 means that 'it has happened a lot or most of the time'.
Once completed, the points for each section (depression, anxiety and stress) are added together and the result is multiplied by 2 to obtain the final score for each category.
Higher scores on each subscale indicate a greater presence of symptoms of depression, anxiety or stress, whilst lower scores reflect a better emotional state.
|
Baseline and Week 8
|
|
Fear Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Baseline and Week 8
|
This scale is based on patients' beliefs about how their pain affects their physical activity and work.
This questionnaire consists of 16 items, of which 5 relate to beliefs regarding physical activity (FABQ-PA) - these are the items we will be assessing.
Each item is rated on a Likert scale from 0 to 6, where 0 means 'strongly disagree' and 6 means 'strongly agree'.
High scores indicate a high level of beliefs that lead to avoidance of activity.
|
Baseline and Week 8
|
|
Clinical Global Impression Scale (CGI)
Time Frame: Baseline and Week 8
|
This scale assesses two aspects: the severity of the illness prior to treatment and the overall improvement following the intervention.
It is a Likert-type scale ranging from 0 to 7. To assess the severity of the illness, 0 corresponds to 'not assessed' and 1 to 'normal, not ill', progressing up to 7, which represents 'among the most severely ill patients'.
As regards overall improvement, 0 corresponds to 'not assessed', 1 to 'much better' and 7 to 'much worse'.
It is a useful tool for assessing severity and response to treatment due to its practicality and clinical validity.
|
Baseline and Week 8
|
|
Qualitative outcomes from focus groups
Time Frame: Week 8
|
The focus-group sessions will be transcribed verbatim in full by a single researcher from the audio recordings.
The transcripts will then be coded inductively and analysed independently by the research team.
The analysis will begin at the most descriptive level, identifying units of meaning, which will be grouped into thematic codes-clusters of units of meaning referring to the same content, and progressively organised into categories, themes, and sub-themes until the main themes emerge.
Beyond this descriptive coding, the analysis will move to an interpretive, inferential level, in which the team draws inferences about the meaning of the emerging themes rather than merely describing them.
As this qualitative strand forms part of a mixed-methods design, these qualitative inferences will subsequently be integrated with the quantitative findings to generate meta-inferences, so that each strand informs and contextualises the other.
|
Week 8
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Sandra S Calvo, Phd, University Zaragoza
- Principal Investigator: Carolina C Jiménez-Sánchez, Phd, San Jorge University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UZ-USJ_Pain-Mental Healht-Phys
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.